Indian Pharma Firms Introduce Generic Semaglutide Injections For Diabetes & Obesity Treatment
Indian drugmakers launch affordable semaglutide injections after patent expiry, expanding access for diabetes and obesity patients across the country.
Centre Reopens PLI Scheme For 11 Drug Products To Boost Domestic Manufacturing
The Department of Pharmaceuticals has invited PLI scheme applications to set up manufacturing for 11 products.
Indian Pharma Sector Sees Strong Growth; Faces Emerging Challenges
McKinsey & Company reports India's pharmaceutical sector grew at an 8% CAGR, with exports rising by 9% in 2024.
